Offering RecordPrivate Equity

IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P.

Captured Sep 9, 2026
Offering amount

$26,450,000

Carried interest

—

Structure

—

Minimum

—

Summary

IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. is a $26,450,000 equity offering listed on iCapital.

The issuer is IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P., organized in New York, offered under Rule 506(c).

Terms shown here are drawn from SEC filing 0002067687-25-000011 and were captured by AltStreet on 2026-09-09. Figures are as disclosed at the time of the offering and are not updated for subsequent performance.

Disclosed Terms

Offering amount
$26,450,000
Status
Open
Exemption
Rule 506(c)
Issuing entity
IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. (New York)
Series family
IEQ Capital Access Fund - Abingworth Clinical Co-Development 3
Launched
2025-07-23
Form D amount sold
$26,450,000
Form D investors
11
Form D amendments
1 (latest 2026-07-21)

Terms as disclosed at the time of the offering. AltStreet does not update these figures for subsequent performance, and a disclosed rate is not a realized return.

Filing Record

The issuer behind IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. files under Regulation D (Form D). Its offering chain runs from D on Jul 14, 2025 to D/A on Jul 21, 2026, 2 filings in all. The latest filing reports $26M sold to 11 investors. AltStreet's status rule reads the chain as raising (filed or amended within 13 months).

  • 2026-07-21First sale reportedD/A$26M
  • 2026-07-21Amount sold increasedD/A$26M
  • 2026-07-21Investor count roseD/A
  • 2026-07-21Large raise reportedD/A$26M
  • 2025-07-14Form D filedD$0

From SEC EDGAR, as filed. Issuer filing history.

Terminal Analysis

Investor

Terminal analysis for this offering

Terminal access unlocks 461 comparable offerings side by side.

Access full research

See what the terminal covers →

Questions About This Offering

What is IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P.?

IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. is a $26,450,000 equity offering listed on iCapital. The issuer is IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P., organized in New York, offered under Rule 506(c). Terms shown here are drawn from SEC filing 0002067687-25-000011 and were captured by AltStreet on 2026-09-09. Figures are as disclosed at the time of the offering and are not updated for subsequent performance.

Who is the issuer of IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P.?

The securities are issued by IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P., organized in New York. The offering relies on Rule 506(c), which permits advertising but limits sales to verified accredited investors. 1 Form D amendment is on record.

How much has IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. raised according to its SEC filing?

The latest Form D on record reports $26,450,000 sold to 11 investors, as of the amendment filed 2026-07-21. Form D figures are as filed and can lag the platform's own progress reporting.

When did IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. launch and close?

The offering launched on 2025-07-23. AltStreet records its status as open.

Is IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. still open to investors?

AltStreet's record shows the offering as open. AltStreet tracks this offering from platform disclosures, last captured 2026-09-09. Offering status changes without a corresponding filing in many cases, so current availability should be confirmed directly with iCapital before acting.

Related Offerings on iCapital

Private Equity offerings on other platforms

All iCapital offerings →All private equity offerings →

Sources & Related Research

AltStreet tracks this offering from primary sources and has no commercial relationship with the platform or issuer. Figures are as disclosed and may be incomplete; offering status changes without a corresponding filing in many cases. This page is informational and is not investment, legal, or tax advice, and it is not an offer to sell or a solicitation to buy any security.